Inderjit Gill, M.D.
NPI 1083737985 · Dermatology Physician · Sycamore, IL
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1083737985
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 036.117339 (IL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
1,391 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 319 | $89 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 271 | $126 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 194 | $6 |
| Biopsy of Related Skin Growth, First Growth11102 | 190 | $91 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 176 | $51 |
| Biopsy of Related Skin Growth, Each Additional Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 20 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 103 | 56 |
| Triamcinolone Acetonide | 57 | 44 |
| Nystatin | 43 | 32 |
| Amoxicillin | 38 | 25 |
| Fluorouracil | 38 | 35 |
| Metronidazole | 35 | 23 |
| Dupilumabbrand: Dupixent Pen | 34 | — |
| Doxycycline Hyclate | 29 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-04-08
- Last updated
- 2020-08-17
- Certified
- 2020-08-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.